VMD update on local anaesthetic shortages
Demand for the drug is particularly high in spring as it is used to provide local and regional anaesthesia for procedures such as calving and lambing.
The Veterinary Medicines Directorate (VMD) has responded to concerns about shortages of products containing the widely used local anaesthetic, procaine hydrochloride.
Some veterinary practices had reported a shortfall in supply due to unforeseen issues with the supply of raw materials, meaning they could only get hold of a fraction of the amount required.
Demand for the drug is particularly high in spring as it is used to provide local and regional anaesthesia for procedures such as calving and lambing, as well as Caesarians, castrations and dehorning of cattle.
In response to concerns from its members, BVA said it sought clarification from the VMD, which has confirmed that the product, Pronestesic, is currently available from suppliers. Normal UK availability for other products is expected to resume in May 2019.
Until then, vets are advised to use due diligence to source a product authorised in the UK, before considering importing an alternative medicine.
BVA president Simon Doherty said: “We’re pleased that VMD has issued some clarification to answer our concerns over procaine hydrochloride shortages... Although we had moved to get assurances sooner, we appreciate that there are formal routes for reporting and that the announcement of any shortage must be handled sensitively to avoid exacerbating the problem.
“VMD’s clarification is especially timely as this is a period of peak seasonal demand for these products. We will keep our members closely informed of any further developments.”
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
